Literature DB >> 26646537

TNF-α and MTHFR Polymorphisms Associated with Cerebral Palsy in Chinese Infants.

Ruiying Hou1, Xiuyu Ren2, Juan Wang2, Xujun Guan3.   

Abstract

This study aims to examine whether the presence of polymorphisms in TNF-α (rs361525 and rs1799724) and MTHFR (rs1476413 and rs9651118) genes is associated with the pathogenesis of cerebral palsy (CP). A total of 105 CP patients and 114 age-, gender-, and ethnicity-matched healthy controls were genotyped for the selected polymorphisms, using TaqMan allelic discrimination assay. Odds ratios (OR) and 95 % confidence intervals (CI) were determined to measure the strength of associations of TNF-α and MTHFR polymorphisms with CP. The proportion of subjects with the gestational age more than 37 weeks or asphyxia was much larger in cases compared with controls (gestational age 63.8 vs. 34.2 %; asphyxia 25.7 vs. 7.9 %). The genotype frequencies of TNF-α rs1799724 were similar between groups (P > 0.05), yet the allele distributions were significantly different (P < 0.05). Both the allele and genotype distributions of MTHFR rs9651118 polymorphism varied significantly between the groups (P < 0.05). Subgroup analysis based on gestational age indicated a significant association between rs361525 and rs9651118 and CP with or without premature. TNF-α protein concentrations were significantly increased among patients with rs361525 GG genotype compared with controls. Also, a significant increase in the risk of CP was observed to be associated with the interactions of TNF-α rs1799724 and MTHFR rs9651118 (OR 2.75, 95 % CI 1.23-6.13). These data suggest that polymorphisms in TNF-α and MTHFR genes might be involved in the pathogenesis of CP in Chinese infants.

Entities:  

Keywords:  Cerebral palsy; MTHFR; Polymorphisms; TNF-α

Mesh:

Substances:

Year:  2015        PMID: 26646537     DOI: 10.1007/s12035-015-9566-7

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  29 in total

1.  Neurotropic viruses and cerebral palsy: population based case-control study.

Authors:  Catherine S Gibson; Alastair H MacLennan; Paul N Goldwater; Eric A Haan; Kevin Priest; Gustaaf A Dekker
Journal:  BMJ       Date:  2006-01-06

2.  TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients.

Authors:  T W Huizinga; R G Westendorp; E L Bollen; V Keijsers; B M Brinkman; J A Langermans; F C Breedveld; C L Verweij; L van de Gaer; L Dams; J B Crusius; A García-Gonzalez; B W van Oosten; C H Polman; A S Peña
Journal:  J Neuroimmunol       Date:  1997-02       Impact factor: 3.478

Review 3.  Epidemiology of cerebral palsy.

Authors:  Kate Himmelmann
Journal:  Handb Clin Neurol       Date:  2013

4.  The significance of TNF-alpha gene polymorphisms in preterm delivery.

Authors:  Elzbieta Drews-Piasecka; Agnieszka Seremak-Mrozikiewicz; Magdalena Barlik; Grazyna Kurzawińska; Hubert Wolski; Anzelma Woyciechowska; Bogusław Czerny; Krzysztof Drews
Journal:  Ginekol Pol       Date:  2014-06       Impact factor: 1.232

5.  Methylenetetrahydrofolate reductase gene polymorphisms and cerebral palsy in Chinese infants.

Authors:  Xiuyong Cheng; Tongchuan Li; Honglian Wang; Dengna Zhu; Caiyun Ma; Bingxiang Ma; Yinghong Wang; Junyu Zhang; Luo Guo; Lei Wang; Liu Yun; Shiting Chen; Zedong Jiang; Lin He; Changlian Zhu; Qinghe Xing
Journal:  J Hum Genet       Date:  2010-10-21       Impact factor: 3.172

Review 6.  Antenatal causes of cerebral palsy: associations between inherited thrombophilias, viral and bacterial infection, and inherited susceptibility to infection.

Authors:  Catherine S Gibson; Alastair H MacLennan; Paul N Goldwater; Gustaaf A Dekker
Journal:  Obstet Gynecol Surv       Date:  2003-03       Impact factor: 2.347

7.  Associations between fetal inherited thrombophilia and adverse pregnancy outcomes.

Authors:  Catherine S Gibson; Alastair H MacLennan; Nard G Janssen; Willem J Kist; William M Hague; Eric A Haan; Paul N Goldwater; Kevin Priest; Gustaaf A Dekker
Journal:  Am J Obstet Gynecol       Date:  2006-04       Impact factor: 8.661

8.  Prothrombotic risk factors in children with hemiplegic cerebral palsy.

Authors:  Nesrin Senbil; Deniz Yüksel; Deniz Yilmaz; Y K Yavuz Gürer
Journal:  Pediatr Int       Date:  2007-10       Impact factor: 1.524

9.  Inflammation at birth is associated with subnormal development in very preterm infants.

Authors:  Ingrid Hansen-Pupp; Anne-Li Hallin; Lena Hellström-Westas; Corrado Cilio; Ann-Cathrine Berg; Karin Stjernqvist; Vineta Fellman; David Ley
Journal:  Pediatr Res       Date:  2008-08       Impact factor: 3.756

10.  A Structured-based Model for the Decreased Activity of Ala222Val and Glu429Ala Methylenetetrahydrofolate Reductase (MTHFR) Mutants.

Authors:  Khuram Shahzad; Abdul Hai; Asifa Ahmed; Nadeem Kizilbash; Jamal Alruwaili
Journal:  Bioinformation       Date:  2013-11-11
View more
  4 in total

1.  Relationship Between TNF-α and the Risk of Cerebral Palsy: A Systematic Review and Meta-Analysis.

Authors:  Baotian Wang; Fan Wang; Xiaoyan Xu; Li Yang; Jing Zhu; Jinjing Yuan; Jiulai Tang
Journal:  Front Neurol       Date:  2022-06-13       Impact factor: 4.086

2.  Correlation of the predisposition of Chinese children to cerebral palsy with nucleotide variation in pri-miR-124 that alters the non-canonical apoptosis pathway.

Authors:  Hui Li; Xiu-Li Wang; Yan-Qiu Wu; Xiu-Mei Liu; Ai-Min Li
Journal:  Acta Pharmacol Sin       Date:  2018-05-17       Impact factor: 6.150

Review 3.  Tumor Necrosis Factor-α T-857C (rs1799724) Polymorphism and Risk of Cancers: A Meta-Analysis.

Authors:  Ping Wang; June Wang; Mingxia Yu; Zhiqiang Li
Journal:  Dis Markers       Date:  2016-12-27       Impact factor: 3.434

4.  Association of NOS1 gene polymorphisms with cerebral palsy in a Han Chinese population: a case-control study.

Authors:  Ting Yu; Lei Xia; Dan Bi; Yangong Wang; Qing Shang; Dengna Zhu; Juan Song; Yong Wang; Xiaoyang Wang; Changlian Zhu; Qinghe Xing
Journal:  BMC Med Genomics       Date:  2018-06-25       Impact factor: 3.063

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.